Premium
Akt inhibitor MK 2206 selectively targets CLL B ‐cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis
Author(s) -
Ding Wei,
Shanafelt Tait D.,
Lesnick Connie E.,
Erlichman Charles,
Leis Jose F.,
Secreto Charla,
Sassoon Traci R.,
Call Timothy G.,
Bowen Deborah A.,
Conte Michael,
Kumar Shaji,
Kay Neil E.
Publication year - 2014
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.12564
Subject(s) - bendamustine , apoptosis , protein kinase b , receptor , cancer research , chemistry , pharmacology , immunology , biology , chronic lymphocytic leukemia , leukemia , biochemistry